Scientist | RNA Biology & Neuromuscular Gene Therapy

NLC- The Healthtech Venture Builder

Nijmegen

On-site

EUR 50,000 - 55,000

Full time

5 days ago
Be an early applicant

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

On-site Nijmegen
Startup culture

Job summary

XtRNA Bio, a spin-out from Radboud University, Nijmegen, seeks a forward-thinking scientist to drive translational R&D on AAV-tRNA platforms for neuromuscular diseases. The role is lab-based on campus and involves designing, executing, and interpreting experiments to advance our tRNA elevation platform.

You will lead research on AAV-tRNA therapies, optimize gene delivery, and conduct in vivo/in vitro efficacy studies in rodent and cellular models, with data analysis, reporting, and

Qualifications

  • PhD in Molecular Biology, Genetics, Neuroscience or related field with strong RNA biology/gene therapy background.
  • Experience with AAV vectors and neuromuscular disease models is highly desirable.
  • Based in the Netherlands and able to work on-site in Nijmegen full-time.
  • Track record of independent research with publications, presentations or patents.
  • Proficiency in rodent model handling and molecular analyses.

Responsibilities

  • Lead research on AAV-tRNA therapies and develop novel constructs for neuromuscular diseases.
  • Optimize gene delivery including capsids, routes and dosage regimens.
  • Conduct in vivo and in vitro efficacy studies in rodent and cellular models.
  • Design and execute in vivo toxicology studies for therapeutic constructs.
  • Contribute to pipeline expansion with suppressor tRNAs and related RNA therapeutics.
  • Interpret complex data, present findings to teams and collaborators.

Skills

RNA biology
Gene therapy
Neuromuscular disease research
AAV vectors
Independent research
Rodent models
Communication
Collaboration

Education

PhD in Molecular Biology/Genetics/Neuroscience

Tools

qPCR
RNA FISH
Northern blotting
Histopathology

Job description

Position Title: Scientist – RNA Biology & Neuromuscular Gene Therapy

  • Location: Radboud University, Nijmegen, the Netherlands
  • Start Date: February 2027
  • Salary: €50,000 to €55,000 gross per year
  • Contract: 1-year contract with renewal possibility
Company Overview

XtRNA Bio is a spin-out from Radboud University, co-founded by Professor Erik Storkebaum and NLC Health Ventures. We aim to deliver disease-modifying treatments that promise to significantly improve the quality of life for patients with severe, unmet medical needs. We are pioneering tRNA-based therapies to correct the root cause of protein translational defects by elevating tRNA pools or expressing suppressor tRNAs. Our team unites expertise in tRNA biology, gene therapy, neuromuscular pathophysiology, and translational therapeutics.

Role Summary

We are looking for a forward-thinking scientist to serve as a key driver of our translational R&D efforts. The position is lab-based on the campus of Radboud University in Nijmegen and involves designing, executing, and interpreting experiments that optimize our AAV-tRNA platforms for neuromuscular disease applications, including studies in relevant animal and in vitro models. The successful candidate will work closely with a research associate and have the support of the scientific director to advance our tRNA elevation platform.

Responsibilities
  • Lead research on AAV-tRNA therapies: Develop and test novel constructs aimed at restoring or enhancing tRNA function in neuromuscular conditions, primarily Charcot-Marie-Tooth disease (CMT).
  • Gene delivery optimization: Evaluate different AAV capsids, administration routes, and dosage regimens to achieve reliable uptake and expression in peripheral motor and sensory neurons.
  • In vivo and in vitro efficacy studies: Execute and supervise experimental workflows in rodent models of neuromuscular disorders, including functional assays (motor performance, histology), molecular analysis (RNA-level readouts), and biomarker evaluation.
  • In vivo toxicology assessment: Design and execute animal studies to evaluate the toxicology profile of our therapeutic constructs.

Pipeline expansion: Contribute to next-generation RNA-based therapeutics by exploring suppressor tRNAs that will form the core of XtRNA Bio’s platform.

  • Data analysis & presentation: Interpret complex datasets and communicate findings to internal teams, external collaborators, and potential investors.
  • Strategic collaboration: Work closely with colleagues in vector manufacturing, quality/regulatory planning, and intellectual property. Participate in cross-functional discussions to align scientific developments with corporate milestones.
Qualifications
  • PhD in Molecular Biology, Genetics, Neuroscience, or related discipline, with a strong background in RNA biology, gene therapy, and/or neuromuscular disease research.
  • Experience working with AAV vectors (design, in vivo administration, analytics) is a major plus, particularly if linked to neuromuscular disease models.
  • Based in the Netherlands and able to work on site in Nijmegen full time.
  • Track record of independent research, evidenced by publications, conference presentations, or patents relevant to RNA therapeutics or gene therapy.
  • Demonstrated proficiency in rodent model handling (Article 9 or FELASA certification, dosing, behavioral assessments, tissue dissection) and subsequent molecular analyses (qPCR, RNA FISH, Northern blotting, histopathology).
  • Entrepreneurial mindset with the adaptability to thrive in a fast-paced, start-up environment.
  • Exceptional communication and collaboration skills, coupled with a passion for tackling challenging scientific and translational problems.
Why join XtRNA Bio?

XtRNA Bio offers a unique opportunity to pioneer the emerging field of tRNA therapeutics for neuromuscular diseases. By joining early, you can directly influence both the scientific trajectory of our programs and the strategic growth of the company. Our dynamic and collaborative culture emphasizes innovation, personal development, and a shared commitment to delivering life-changing therapies for patients.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Scientist | RNA Biology & Neuromuscular Gene Therapy
Scientist | RNA Biology & Neuromuscular Gene Therapy

CAREERS AT NLC • Nijmegen

On-site
EUR 50,000 - 55,000
Scientist – RNA Biology & Neuromuscular Gene Therapy (AAV)
Scientist – RNA Biology & Neuromuscular Gene Therapy (AAV)

CAREERS AT NLC • Nijmegen

On-site
EUR 50,000 - 55,000
RNA Biology Scientist - Neuromuscular Gene Therapy
RNA Biology Scientist - Neuromuscular Gene Therapy

NLC- The Healthtech Venture Builder • Nijmegen

On-site
EUR 50,000 - 55,000
On-site Nijmegen
Startup culture
CEO (Gene Therapy) XtRNA
CEO (Gene Therapy) XtRNA

NLC Health Ventures • Nijmegen

Hybrid
EUR 90,000 - 150,000
Equity-based compensation
Modest base salary until fundraising
CEO (Gene Therapy) XtRNA
CEO (Gene Therapy) XtRNA

NLC- The Healthtech Venture Builder • Nijmegen

On-site
EUR 120,000 - 180,000
Equity-based compensation
Modest base salary until fundraising
Director Toxicology
Director Toxicology

ProQR Therapeutics N.V. • Netherlands

On-site
EUR 150,000 - 190,000
Annual bonus
Stock options
Pension plan
+3
Director Toxicology
Director Toxicology

ProQR Therapeutics • Leiden

On-site
EUR 140,000 - 180,000
8% holiday allowance
30 vacation days
Annual performance bonus
+6
Internal link Director Toxicology
Internal link Director Toxicology

ProQR Therapeutics • Leiden

On-site
EUR 180,000 - 260,000
8% holiday allowance
30 vacation days
Annual performance bonus
+6
CEO, RNA Therapeutics Startup: Lead Gene Therapy Breakthroughs
CEO, RNA Therapeutics Startup: Lead Gene Therapy Breakthroughs

NLC Health Ventures • Nijmegen

Hybrid
EUR 90,000 - 150,000
Equity-based compensation
Modest base salary until fundraising
Director, Nonclinical Toxicology — RNA Therapeutics
Director, Nonclinical Toxicology — RNA Therapeutics

ProQR Therapeutics NV • Leiden

On-site
EUR 180,000 - 260,000
8% holiday allowance
30 vacation days
Annual performance bonus
+6